CSL Behring
King of Prussia, Pennsylvania
CSL Behring is one of the world's largest manufacturers of plasma-derived and recombinant therapies. They are a leading producer of immunoglobulin products used to treat CIDP, PIDD, and other immune-mediated conditions. CSL Behring's portfolio includes several IVIG and subcutaneous immunoglobulin products that are critical for patients with rare diseases.
Drugs
Hub Program — CSL Behring IgIQ
- ✓Insurance verification and prior authorization support
- ✓Copay assistance for eligible commercially insured patients
- ✓Patient assistance program for uninsured or underinsured patients
- ✓Infusion nurse coordination for home therapy
- ✓Ongoing therapy management and refill coordination
Patient Assistance
Copay Assistance
CSL Behring offers copay assistance programs for commercially insured patients, potentially reducing out-of-pocket costs to $0 for eligible patients on Hizentra and Privigen.
Patient Assistance Program (PAP)
The CSL Behring Patient Assistance Program provides free medication to eligible uninsured or underinsured patients who meet income requirements.
Denied a CSL Behring Drug?
Ellen can decode your denial, identify the specific reason, and generate a personalized appeal letter — free.